Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-29

Clinical Trial Update: Contrastim Stroke Trial [Phase 1, Phase 2]

View source ↗

Summary

The Contrastim Stroke Trial, a Phase 1/2 study, has completed and posted results. The sponsor is Shirley Ryan AbilityLab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Contrastim

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-12-29